Medical devices, healthcare technology and the business of care
510(k) clearance · K260528

OncoStudio

Oncosoft. Inc., · Decision date Jul 2, 2026

FDA DECISIONK260528

What did the FDA decide?

FDA records K260528 as a 510(k) premarket notification, with a decision dated Jul 2, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Jul 2, 2026

FDA source record

Regulatory record facts

Identifier
K260528
Regulatory pathway
510(k) premarket notification
Product code
QKB
Decision code
SESE
Decision date
Jul 2, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Radiological Image Processing Software For Radiation Therapy.

Product code
QKB
FDA device class
2

FDA decision timeline

  1. K260528 received

    Application receipt date recorded by FDA.

  2. K260528 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QKB

Product / regulatory recordCompanyPathwayDecision dateSource
Radformation, Inc.510(k) clearanceAug 14, 2026FDA
Varian Medical Systems510(k) clearanceJul 10, 2026FDA
Aitewan Biomedical Technology, Inc.510(k) clearanceApr 10, 2026FDA
Siemens Healthcare GmbH510(k) clearanceApr 10, 2026FDA
Mim Software, Inc.510(k) clearanceMar 27, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Oncosoft. Inc.,

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Seoul

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records